High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection-Reference-Cited by-同舟云学术

High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection

Published:2013-12-31 Issue:1 Volume:37 Page:41-52
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Labots Mariette,Buffart Tineke E.,Haan Josien C.,van Grieken Nicole C. T.,Tijssen Marianne,van de Velde Cornelis J. H.,Grabsch Heike I.,Ylstra Bauke,Carvalho Beatriz,Fijneman Remond J. A.,Verheul Henk M. W.,Meijer Gerrit A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13402-013-0162-4.pdf

Reference53 articles.

1. D. Cunningham, N. Starling, S. Rao, T. Iveson, M. Nicolson, F. Coxon, G. Middleton, F. Daniel, J. Oates, A.R. Norman, Capecitabine and oxaliplatin for advanced esophagogastric cancer. N. Engl. J. Med. 358, 36–46 (2008)

2. E. Van Cutsem, V.M. Moiseyenko, S. Tjulandin, A. Majlis, M. Constenla, C. Boni, A. Rodrigues, M. Fodor, Y. Chao, E. Voznyi, M.L. Risse, J.A. Ajani, Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J. Clin. Oncol. 24, 4991–4997 (2006)

3. A.D. Wagner, S. Unverzagt, W. Grothe, G. Kleber, A. Grothey, J. Haerting, W.E. Fleig, Chemotherapy for advanced gastric cancer. Cochrane Database Syst. Rev., CD004064 (2010)

4. A.D. Wagner, W. Grothe, J. Haerting, G. Kleber, A. Grothey, W.E. Fleig, Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J. Clin. Oncol. 24, 2903–2909 (2006)

5. V. Catalano, F. Graziano, D. Santini, S. D'Emidio, A.M. Baldelli, D. Rossi, B. Vincenzi, P. Giordani, P. Alessandroni, E. Testa, G. Tonini, G. Catalano, Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br. J. Cancer 99, 1402–1407 (2008)

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15

2. Tumor cell enrichment by tissue suspension improves sensitivity to copy number variation in diffuse gastric cancer with low tumor content;Scientific Reports;2024-06-13

3. Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment;Frontiers in Genetics;2022-06-08

Exon Coverage Variations Between Cancer Tissues and Adjacent Non-Cancerous Tissues are Prognostic Factors in Gastric Cancer

;OncoTargets and Therapy;2020-01

5. Activation of LXRβ inhibits proliferation, promotes apoptosis, and increases chemosensitivity of gastric cancer cells by upregulating the expression of ATF4;Journal of Cellular Biochemistry;2019-06-18